Cargando…

APOL1 Risk Variants Independently Associated With Early Cardiovascular Disease Death

INTRODUCTION: The relationship of APOL1 renal risk variants to cardiovascular disease (CVD) is controversial and was the subject of this investigation. METHODS: Age, cause of death, and nephrosclerosis (the latter defined by glomerulosclerosis) were analyzed in the autopsies of 162 African Americans...

Descripción completa

Detalles Bibliográficos
Autores principales: Hughson, Michael D., Hoy, Wendy E., Mott, Susan A., Bertram, John F., Winkler, Cheryl A., Kopp, Jeffrey B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762961/
https://www.ncbi.nlm.nih.gov/pubmed/29340318
http://dx.doi.org/10.1016/j.ekir.2017.08.007
_version_ 1783291800279056384
author Hughson, Michael D.
Hoy, Wendy E.
Mott, Susan A.
Bertram, John F.
Winkler, Cheryl A.
Kopp, Jeffrey B.
author_facet Hughson, Michael D.
Hoy, Wendy E.
Mott, Susan A.
Bertram, John F.
Winkler, Cheryl A.
Kopp, Jeffrey B.
author_sort Hughson, Michael D.
collection PubMed
description INTRODUCTION: The relationship of APOL1 renal risk variants to cardiovascular disease (CVD) is controversial and was the subject of this investigation. METHODS: Age, cause of death, and nephrosclerosis (the latter defined by glomerulosclerosis) were analyzed in the autopsies of 162 African Americans and 136 whites genotyped for APOL1 risk alleles. RESULTS: Sudden deaths represented >75% of CVD autopsies for both races and all-risk genotypes. The average ages of CVD deaths for African Americans with 1 and 2 APOL1 risk alleles were, respectively, 7.0 years (P = 0.02) and 12.2 years (P < 0.01) younger than African Americans with 0 risk alleles and 8.7 years (P = 0.01) and 13.9 years (P = 0.01) younger than whites. Age differences were not significant between African Americans and whites with 0 risk alleles (P = 0.61). The younger CVD deaths of African Americans were associated with less severe glomerulosclerosis with 2 (P = 0.01), although not 1 (P = 0.09), compared with 0 APOL1 risk alleles. Cardiomyopathy was found in 23% of African Americans with 1 and 2 risk alleles and significantly contributed to the lower age (P = 0.01). For non-CVD deaths, age differences were not seen by race (P = 0.28) or among African Americans by risk allele status (P = 0.38). CONCLUSION: Carriage of 1 or 2 APOL1 risk alleles in African Americans was associated with earlier age deaths due to coronary artery disease and cardiomyopathy. For 2 risk alleles, the early age was independent of nephrosclerosis.
format Online
Article
Text
id pubmed-5762961
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-57629612018-01-16 APOL1 Risk Variants Independently Associated With Early Cardiovascular Disease Death Hughson, Michael D. Hoy, Wendy E. Mott, Susan A. Bertram, John F. Winkler, Cheryl A. Kopp, Jeffrey B. Kidney Int Rep Clinical Research INTRODUCTION: The relationship of APOL1 renal risk variants to cardiovascular disease (CVD) is controversial and was the subject of this investigation. METHODS: Age, cause of death, and nephrosclerosis (the latter defined by glomerulosclerosis) were analyzed in the autopsies of 162 African Americans and 136 whites genotyped for APOL1 risk alleles. RESULTS: Sudden deaths represented >75% of CVD autopsies for both races and all-risk genotypes. The average ages of CVD deaths for African Americans with 1 and 2 APOL1 risk alleles were, respectively, 7.0 years (P = 0.02) and 12.2 years (P < 0.01) younger than African Americans with 0 risk alleles and 8.7 years (P = 0.01) and 13.9 years (P = 0.01) younger than whites. Age differences were not significant between African Americans and whites with 0 risk alleles (P = 0.61). The younger CVD deaths of African Americans were associated with less severe glomerulosclerosis with 2 (P = 0.01), although not 1 (P = 0.09), compared with 0 APOL1 risk alleles. Cardiomyopathy was found in 23% of African Americans with 1 and 2 risk alleles and significantly contributed to the lower age (P = 0.01). For non-CVD deaths, age differences were not seen by race (P = 0.28) or among African Americans by risk allele status (P = 0.38). CONCLUSION: Carriage of 1 or 2 APOL1 risk alleles in African Americans was associated with earlier age deaths due to coronary artery disease and cardiomyopathy. For 2 risk alleles, the early age was independent of nephrosclerosis. Elsevier 2017-08-24 /pmc/articles/PMC5762961/ /pubmed/29340318 http://dx.doi.org/10.1016/j.ekir.2017.08.007 Text en © 2017 International Society of Nephrology. Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Clinical Research
Hughson, Michael D.
Hoy, Wendy E.
Mott, Susan A.
Bertram, John F.
Winkler, Cheryl A.
Kopp, Jeffrey B.
APOL1 Risk Variants Independently Associated With Early Cardiovascular Disease Death
title APOL1 Risk Variants Independently Associated With Early Cardiovascular Disease Death
title_full APOL1 Risk Variants Independently Associated With Early Cardiovascular Disease Death
title_fullStr APOL1 Risk Variants Independently Associated With Early Cardiovascular Disease Death
title_full_unstemmed APOL1 Risk Variants Independently Associated With Early Cardiovascular Disease Death
title_short APOL1 Risk Variants Independently Associated With Early Cardiovascular Disease Death
title_sort apol1 risk variants independently associated with early cardiovascular disease death
topic Clinical Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762961/
https://www.ncbi.nlm.nih.gov/pubmed/29340318
http://dx.doi.org/10.1016/j.ekir.2017.08.007
work_keys_str_mv AT hughsonmichaeld apol1riskvariantsindependentlyassociatedwithearlycardiovasculardiseasedeath
AT hoywendye apol1riskvariantsindependentlyassociatedwithearlycardiovasculardiseasedeath
AT mottsusana apol1riskvariantsindependentlyassociatedwithearlycardiovasculardiseasedeath
AT bertramjohnf apol1riskvariantsindependentlyassociatedwithearlycardiovasculardiseasedeath
AT winklercheryla apol1riskvariantsindependentlyassociatedwithearlycardiovasculardiseasedeath
AT koppjeffreyb apol1riskvariantsindependentlyassociatedwithearlycardiovasculardiseasedeath